Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley closed $8.38 short of its 52-week high ($136.24), which the company achieved on November 25th.

Shares of Morgan Stanley MS shed 1.37% to $126.88 Tuesday, on what proved to be an all-around dismal trading session for the ...

Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to $113 from $87 on HIV prevention drug Lenacapavir (PrEP) and next-gen HIV ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

Morgan Stanley (MS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Morgan Stanley (NYSE:MS – Get Free Report) is set to issue its quarterly earnings data before the market opens on Thursday, ...

Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley MS. And retail traders should know. We ...

In a report released today, Jason Goldberg from Barclays maintained a Buy rating on Morgan Stanley (MS – Research Report), with a price target ...

Jefferies analyst Daniel Fannon maintained a Buy rating on Morgan Stanley (MS – Research Report) today and set a price target of $144.00. The ...

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

Neville Rodie & Shaw Inc. bought a new stake in shares of Morgan Stanley (NYSE:MS – Free Report) during the 4th quarter, ...